nanotech
NanoBio Patents Drug Tech
Filed in archive Business by jeff goldman on February 3, 2010
NanoBio Patents Drug Tech


NanoBio Corp., based in Ann Arbor, Mich., has been awarded a patent for the technology behind its anti-infection and dermatology drugs.


"We are very pleased with this patent award in that the new claims circumscribe all of NanoBio's anti-infective and dermatological products, as well as our intranasal and intramuscular vaccine adjuvants," says company CEO and founder James R. Baker, Jr., MD.


"The patent, NanoBio's sixth, comes after the firm struck a multimillion-dollar licensing deal with United Kingdom-based pharmaceutical giant GlaxoSmithKline to license NanoBio's cold sore treatment still in clinical development," writes AnnArbor.com's Nathan Bomey.


"The company has several drugs under development, all based on its Nanostat technology platform, which delivers drugs through the skin or nasal passages rather than using needles," writes MedCity News' Brandon Glenn.


The press release is here.




Permalink: NanoBio Patents Drug Tech
Tags: NanoBio  Michigan  dermatology  dermatological  drug  patent  intranasal  intramuscular  vaccine  GlaxoSmithK 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/172046
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for NanoBio Patents Drug Tech:

  • Currently 10.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 10.00 out of 1 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!